Cargando…
Von Willebrand factor in the plasma and in the tumor tissue predicts cancer-associated thrombosis and mortality
Autores principales: | Karampinis, Ioannis, Nowak, Kai, Koett, Julian, Mess, Christian, Wagner, Laura, Gaiser, Timo, Mayer, Frank Thomas, Goertz, Lukas, Schneider, Stefan Werner, Bauer, Alexander Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827172/ https://www.ncbi.nlm.nih.gov/pubmed/36134455 http://dx.doi.org/10.3324/haematol.2022.281315 |
Ejemplares similares
-
Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis
por: Goertz, Lukas, et al.
Publicado: (2016) -
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
por: Stadler, Julia-Christina, et al.
Publicado: (2023) -
Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010) -
Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
por: Bauer, Alexander, et al.
Publicado: (2023) -
von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO
por: Valladolid, Christian, et al.
Publicado: (2018)